An advance on new generations of chemotherapy and antiviral drugs

September 8, 2008
Above is an illustration of DNA polymerase moving along the length of a DNA strand. Researchers are targeting new chemotherapy drugs that efficiently block uncontrolled DNA replication while minimizing side effects. Credit: The Protein Data Bank

Researchers are describing progress toward developing a new generation of chemotherapy agents that target and block uncontrolled DNA replication — a hallmark of cancer, viral infections, and other diseases — more effectively than current drugs in ways that may produce fewer side effects. Their article is scheduled for the Aug. 27 issue of ACS' Biochemistry.

In the article, Anthony J. Berdis updates and reviews worldwide research efforts to develop drugs that target DNA polymerases, the enzymes responsible for assembling DNA from its component parts.

Several promising strategies are already in use that inhibit uncontrolled DNA replication, particularly in anticancer therapy, but most produce severe side effects and are hampered by drug resistance, the researcher notes.

Berdis says that one of the more promising strategies to date involves the use of so-called nucleoside analogues, artificial pieces of DNA that inhibit replication by substituting for natural segments. Most nucleoside analogues directly target the active site of the polymerase enzyme, a non-specific approach that can also harm healthy cells which contain the enzyme.

Berdis describes an alternative approach in which the drugs directly target damaged DNA while avoiding healthy DNA, side-stepping the polymerase enzymes of normal cells. The development, which shows promise in preliminary lab studies, could lead to improved nucleoside analogues with fewer side effects, he says.

Article: "DNA Polymerases as Therapeutic Targets"; dx.doi.org/10.1021/bi801179f

Source: American Chemical Society

Explore further: New DNA cleavage technique could lead to more versatile genetic engineering

Related Stories

Hope for new treatment for Huntington's disease

February 20, 2017

Researchers working at Karolinska Institutet in Sweden and University of Southern Denmark have managed to produce short synthetic DNA analogues – oligonucleotides – that bind directly to the gene that is mutated in Huntington's ...

New treatment for African sleeping sickness comes closer

November 6, 2013

Researchers at Umeå University have identified drugs targeting infections of the parasite Trypanosoma brucei and are thereby well on the way to find a cure against African sleeping sickness. This is the kernel of a thesis, ...

Recommended for you

Quantum data takes a ride on sound waves

September 22, 2017

Yale scientists have created a simple-to-produce device that uses sound waves to store quantum information and convert it from one form to another, all inside a single, integrated chip.

Stressed-out meerkats less likely to help group

September 22, 2017

Dominant female meerkats use aggression to keep subordinates from breeding, but a new study finds this negative behavior also can result in the latter becoming less willing to help within the group.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.